Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies

April 23, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has advanced an analytical method used to measure and control a key polymer within its PNKP Inhibitor Technology (the "Technology"), supporting continued formulation development and scale-up as the Company advances toward its goal of clinical manufacturing. This work is intended to help ensure consistency in...

Read more

Hillsboro Health Recognized Among Nation's Top Rural Hospitals

April 23, 2026 5:05 PM

Hillsboro Health has been ranked one of the Top 20 Critical Access Hospitals in the nation for Best Practices in Patient Satisfaction by the National Rural Health Association. The recognition highlights Hillsboro Health's commitment to providing care that patients trust, value and recommend. The award places Hillsboro Health among the nation's top rural hospitals for patient satisfaction."This recognition shows the dedication of our team members...

Read more

BUDZ Highlights Valuable Legacy Genetics Portfolio Following Historic Federal Schedule III Marijuana Action WEED Inc. (OTCQB:BUDZ) Positioned with Rare Landrace Strains as DOJ Announces Immediate Schedule III Pathway for Qualified Medical Marijuana Products

April 23, 2026 4:35 PM

WEED Inc. (OTCQB:BUDZ) ("BUDZ" or the "Company"), a cannabis bioresearch and genetics-focused public company, today issued a strategic corporate update following the U.S. Department of Justice and Drug Enforcement Administration announcement placing FDA-approved marijuana products and marijuana products subject to qualifying state-issued medical licenses into Schedule III of the Controlled Substances Act, while beginning an expedited hearing...

Read more

Trump Marijuana Schedule III Is Not Deregulation - It Activates U.S. Treaty Obligations and Federal Cannabis Quotas

April 23, 2026 3:50 PM

The recent decision by the U.S. Attorney General and the Drug Enforcement Administration to move certain forms of medical marijuana into Schedule III marks the beginning-not the end-of federal cannabis regulation.While many operators are celebrating anticipated tax relief under Section 280E, few are recognizing what the rescheduling order actually triggers: International treaty compliance, federal quota control, and DEA oversight of the...

Read more

TailorMed Expands its Solutions Suite to Address Barriers Across the Medication Journey, Building on its Market-Leading Affordability Solution and Growing its National Network

April 23, 2026 10:00 AM

TailorMed, the medication success platform removing barriers across the patient journey, today announced a new chapter in its growth, extending its affordability solutions to tackle additional barriers across access and adherence.While affordability remains a core challenge, patients often encounter multiple barriers that prevent them from starting and staying on therapy, from delays at the point of prescription to lack of ongoing support after...

Read more

Zen Hut Launches Refined London Wellness Model Centered on Fair Therapist Pay

April 23, 2026 9:35 AM

Zen Hut, the at home wellness app developed by the team behind The Massage People, today announced the launch of its refined London service model following several years of testing, iteration, and brand development.The wider business first entered the market more than 10 years ago through The Massage People, building operational experience in mobile massage, therapist recruitment, customer support, and booking technology. In 2023, the company...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Accelerates Growth Strategy with Strategic Capital Raise Following Launch of AI Consumer Platform

April 23, 2026 9:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a strategic capital raise designed to accelerate the Company's rapid transition into a revenue-generating artificial intelligence platform company.This initiative follows the successful launch of Snapshot Recipes, the Company's first consumer-facing AI mobile application-marking a major milestone as Medical Care Technologies evolves from development into active commercialization.The...

Read more

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026

April 23, 2026 9:00 AM

In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results which were consistent with its previously announced projections for calendar year 2026. But because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative of comparative results for the year as a whole.Summary of results.The following is a...

Read more

Aetna Better Health(R) of Virginia Opens New Community Resource Center in Roanoke

April 23, 2026 9:00 AM

Originally published on CVS Health Company NewsAetna Better Health® of Virginia, a CVS Health® company (NYSE:CVS), announced the opening of its new Community Resource Center (CRC) in Roanoke, located at the Roanoke Redevelopment and Housing Authority's EnVision Center. The CRC is open to the public and expands access to health and wellness services by helping individuals and families navigate health care benefits, connect to local resources and...

Read more

Nation's Top Medical Equipment Rental Provider Expands to Portland as Oregon Hospitals Confront Nation's Second-Tightest Bed Supply

April 23, 2026 9:00 AM

US Med-Equip, recognized as the nation's "best" medical equipment rental provider, opened a Portland branch to deliver life-saving equipment at a moment's notice to hospitals across Oregon and Southwest Washington as the region prepares for one of its largest inpatient capacity expansions in decades. Oregon's growing 65-and-older population is projected to outnumber residents under 18 within the next several years, driving demand for critical...

Read more

Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114

April 23, 2026 8:15 AM

Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company pioneering first-in-class neuropeptide therapies for stress-related neuropsychiatric disorders, today announced the appointment of Bill Nichols Jr. as President. This strategic leadership addition, combined with a thoughtful optimization of the Company's management structure, sharpens focus and resources on advancing its lead candidate, PT00114 - positioning...

Read more

Manatee Appoints Dr. Neha Chaudhary, Harvard Child Psychiatrist and Pioneer in Digital Mental Health, to Board of Directors

April 23, 2026 8:00 AM

Manatee, a virtual provider of structured, whole-family mental health care, today announced the appointment of Neha Chaudhary, MD, as an Independent Director to its Board of Directors.Dr. Chaudhary is a double board-certified child and adolescent psychiatrist on faculty at Harvard Medical School and Massachusetts General Hospital, co-founder of Brainstorm, Stanford's Lab for Mental Health Innovation, and currently Chief Medical Officer at...

Read more

2026 State of Digital Healthcare in Oncology Report Reveals Cancer Programs Are Rewiring Buying Around Speed to Treatment, Infusion Economics, and Precision Workflow - Black Book

April 23, 2026 7:15 AM

Black Book Research today announced the release of its new 2026 State of Digital Healthcare in Oncology Centers of Excellence, Chemotherapy and Infusion Networks, and Cancer Centers, a comprehensive market intelligence report examining how U.S. cancer programs are redesigning digital strategy across access, authorization, infusion, specialty pharmacy, pathology, genomics, navigation, analytics, research, and reimbursement.The report is based on...

Read more

Sisel International Appoints Pamela Ferry as General Manager of Australia and New Zealand to Support Regional Expansion

April 23, 2026 7:00 AM

Sisel International today announced that it has appointed Pamela Ferry as General Manager of Australia and New Zealand as the company accelerates its expansion and transitions to full market operations across the region.Ferry brings more than 20 years of experience in the global direct selling industry, with a focus on international market expansion, distributor growth, and leadership development, including experience supporting the relaunch of...

Read more

Dosell Awarded Contract with Västervik Municipality Regarding Medication Dispensing Devices

April 23, 2026 2:50 AM

iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) announces that its subsidiary Dosell AB, together with Atea Sverige AB, has been awarded a contract with Västervik Municipality and cooperating municipalities regarding the supply of medication dispensing devices.The award relates to tender area Group B, simple medication dispensing device, where Dosell is offered as a solution for medication management within municipal healthcare and social...

Read more

TridentCare Partners with ServiceNow to Power AI-Driven Transformation Across Operations

April 22, 2026 5:30 PM

TridentCare, the nation's leading provider of portable diagnostic services, today announced a strategic partnership with ServiceNow, the AI control tower for business reinvention, to transform how the company manages its end-to-end operations - from the moment a customer places an order through diagnostic delivery, results reporting, and reimbursement.The partnership builds on TridentCare's successful deployment of ServiceNow Field Service...

Read more

XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation

April 22, 2026 4:10 PM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, the results from the HOPE-at-Heart clinical trial (NCT06485596) were presented at the ISHLT Annual Meeting in Toronto. This prospective, multicenter trial, is the first to evaluate direct procurement of donor hearts after circulatory death (DCD) followed by preservation using HOPE with the XVIVO Heart Assist Transport. The trial successfully met its pre-specified primary...

Read more

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

April 22, 2026 4:10 PM

Emerging Growth Research today announced the release of a Flash Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), reiterating its Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's recent share price of $3.65 as of April 21, 2026.The Flash Report provides an update following recent share price volatility tied to a secondary share transaction, while reaffirming the...

Read more

Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO's Heart Technology Presented at ISHLT in Toronto

April 22, 2026 3:55 PM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, preliminary one-year follow-up data from the US PRESERVE trial of XVIVO's investigational heart technology, ‘PRESERVE: A Prospective, Multi-center, Single-arm, Open-label Study,' were presented by the trial's principal investigator, Dr. Victor Pretorius, at the annual ISHLT conference in Toronto, Canada. The PRESERVE trial was designed to assess pre-specified safety and effectiveness...

Read more

ALL EYES ON CMS: Federal Fight Could Decide Whether Unapproved Cannabinoids Reach America's Seniors

April 22, 2026 2:45 PM

MMJ International Holdings today strongly rejected arguments by federal regulators that plaintiffs lack standing to challenge the Centers for Medicare & Medicaid Services' cannabinoid-access framework for hemp derived products. The government's assertion that participation by a pharmaceutical cannabinoid developer does not strengthen the case misunderstands both the structure of federal drug regulation and the real world impact of CMS policy...

Read more